Skip to main content
Fig. 4 | BMC Systems Biology

Fig. 4

From: How to schedule VEGF and PD-1 inhibitors in combination cancer therapy?

Fig. 4

Growth of tumor volume under treatment with γB or γA, or combination (γB,γA). The anti-VEGF or/and the anti-PD-1 treatment started at day 0 and continued for 10 days. a γB=3×10−8g/cm3·day,γA=3×10−8g/cm3·day; b γB=3.5×10−8g/cm3·day,γA=0.5×10−8g/cm3·day. All other parameters are same as in Fig. 3

Back to article page